Aridis Pharmaceuticals, Inc. — Operating Income by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/af90f51c-1164-4b48-9823-f24442455182/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2022 | $-30.0M | 2022-01-01 – 2022-12-31 | evidence 0001493152-23-018590 |
| FY 2021 | $-42.7M | 2021-01-01 – 2021-12-31 | evidence 0001104659-22-045482 |
| FY 2020 | $-22.4M | 2020-01-01 – 2020-12-31 | evidence 0001104659-21-044023 |
| FY 2019 | $-29.1M | 2019-01-01 – 2019-12-31 | evidence 0001047469-20-002189 |
| FY 2018 | $-24.1M | 2018-01-01 – 2018-12-31 | evidence 0001047469-19-001721 |
| FY 2017 | $-19.7M | 2017-01-01 – 2017-12-31 | evidence 0001047469-19-001721 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Aridis Pharmaceuticals, Inc. — all facts · Revenue · Net Income